Benjamin Jurg joines Peracutus as our new CEO
On 1 April, Benjamin Jurg joined Peracutus as Chief Executive Officer (CEO). This addition to the team provides the expertise needed to make the product launch of the Peracutus Volue possible.
Symposium Edema unlocked Ghent 2025
Peracutus was present as a sponsor on the symposium 'lymfoedema unlocked'. The symposium was held in the Oehoe auditorium of the campus Coupure of the University of Ghent, Belgium. Several health professionals visited our stand and fruitfull conversations were held…
We participate in Health Impact Accelerator
We are proud to announce that today, we are selected to participate as one of the five teams in the Health Impact Accelerator 2025 of Health Holland (zorginnovatie.nl). For us this program is well timed to support us in becoming…
Future of Preventitive Medicine & Public Health 2023
In March 2023, Peracutus presented the Volue as invited speaker at the 3rd international conference on Future of Preventive Medicine & Public Health, in Barcelona (Spain). The contribution was rewarded with a Certificate of Recognition.